首页 产品目录 分子砌块 按应用领域 分子与化学生命科学 生化试剂 药物研究试剂 7-(4-(4-(2,3-二氯苯基)哌嗪-1-基)丁氧基)-3,4-二氢喹啉-2(1H)-酮

7-(4-(4-(2,3-二氯苯基)哌嗪-1-基)丁氧基)-3,4-二氢喹啉-2(1H)-酮

7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
1g 98% 询价
- +
5g 98% 询价
- +
10g 98% 询价
- +
25g 98% 询价
- +
100g 98% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

129722-12-9

中文名称

7-(4-(4-(2,3-二氯苯基)哌嗪-1-基)丁氧基)-3,4-二氢喹啉-2(1H)-酮

英文名称

7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one

别名

7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril | Aripiprazole [USAN:INN:BAN] | Aripiprazole- Bio-X | HMS3373D04 | Asprito | BCP04902 | OPC-14597 | s1975 | Aripiprex | Pripiprazole | Abilify Maintena Kit | Abilify MyCite

标准英文名

7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one

MDL No.

MFCD00892072

分子式

C23H27Cl2N3O2

分子量

447.15

精确分子量

447.15

SMILES

O=C1NC2=CC(OCCCCN3CCN(CC3)C4=C(Cl)C(Cl)=CC=C4)=CC=C2CC1

标准SMILES

O=C1CCC2=CC=C(C=C2N1)OCCCCN1CCN(CC1)C1C=CC=C(Cl)C=1Cl

用途

Aripiprazole is indicated for the treatment of schizophrenia in individuals aged 13 years and older, including maintenance treatment; for monotherapy or adjunctive therapy in the treatment of acute manic or mixed episodes associated with bipolar I disorder in patients aged 10 years and older; for maintenance treatment of bipolar I disorder as monotherapy or in combination with other medications; as adjunctive therapy in major depressive disorder; and for the treatment of irritability associated with autistic disorder in pediatric patients aged 6 to 17 years. The intramuscular formulation is used for the management of acute agitation associated with schizophrenia or bipolar I disorder. Additionally, aripiprazole is sometimes used off-label for other psychiatric conditions such as delusional disorder, behavioral disturbances associated with dementia, childhood and adolescent behavioral disorders, and impulse control disorders. In China, its approved indication is limited to schizophrenia.

InChIKey

CEUORZQYGODEFX-UHFFFAOYSA-N

安全信息

SureRoute逆合成路线

1.  129722-12-9 逆合成路线 1

ACRJWD058
120004-79-7
ACHCZJ790
129722-12-9
来源: SureRoute

2.  129722-12-9 逆合成路线 2

ACBMEF635
129722-34-5
ACHCZJ790
129722-12-9
来源: SureRoute

3.  129722-12-9 逆合成路线 3

—
—
ACRJWD058
120004-79-7
ACHCZJ790
129722-12-9
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手